Clinical Trial Update: RCT of Methotrexate Added to Treatment As Usual in Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 randomized trial assessed adding methotrexate to treatment as usual in schizophrenia and related disorders; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Pakistan Institute of Living and Learning | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED